General Information
Version
6.5
Revision date
2024-03-08
Product name
TLR1/TLR2 Antagonist, CU-CPT22
CAS No.
1416324-85-0
REACH No
A
1.2.1 Relevant identified uses
Biochemical research/analysis
Emergency telephone
+44 (0)870 8200418
Icons in SDS
Company Information
company name
Merck Life Science UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
none
Hazard Codes
Hazard statements (CLP)
H334, H410
Hazard statements
Code
Statements
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Respiratory sensitization, H334: May cause allergy or asthma (Category 1) symptoms or breathing difficulties if inhaled. Short-term (acute) aquatic H400: Very toxic to aquatic life. hazard, (Category 1) Long-term (chronic) aquatic H410: Very toxic to aquatic life with long hazard, (Category 1) lasting effects.
Hazard pictograms
none
Signal word
none Danger Danger
Hazard statements
none H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H410 Very toxic to aquatic life with long lasting effects. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary statements
none P261 Avoid breathing dust. P273 Avoid release to the environment. P284 Wear respiratory protection. P391 Collect spillage. P501 Dispose of contents/ container to an approved waste disposal plant. P261 Avoid breathing dust. P284 Wear respiratory protection. P501 Dispose of contents/ container to an approved waste disposal plant.
Supplemental label elements
none none Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
